Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Bruno Mégarbane, Emuri Abe & Lucie Chevillard. (2022) Glimepiride pharmacokinetics in overdose. Clinical Toxicology 60:11, pages 1284-1285.
Read now
Read now
Lois E. Brustman, Oded Langer, Brianne Bimson, Sophia Scarpelli & Manal El Daouk. (2016) Weight gain in gestational diabetes: the effect of treatment modality. The Journal of Maternal-Fetal & Neonatal Medicine 29:7, pages 1025-1029.
Read now
Read now
Andreas Pfützner, Birgit Wilhelm & Thomas Forst. (2007) Rosiglitazone and glimeperide: review of clinical results supporting a fixed dose combination. Vascular Health and Risk Management 3:2, pages 211-220.
Read now
Read now
Thomas Forst & Andreas Pfützner. (2007) Fixed-dose combination of pioglitazone and glimepiride in the treatment of Type 2 diabetes mellitus. Expert Review of Endocrinology & Metabolism 2:3, pages 303-312.
Read now
Read now
Lydia Rabbaa‐Khabbaz, Rita Abi Daoud, Dolla Karam‐Sarkis, Chawki Atallah & Antoine Zoghbi. (2005) A Simple and Sensitive Method for Determination of Glimepiride in Human Serum by HPLC. Journal of Liquid Chromatography & Related Technologies 28:20, pages 3255-3263.
Read now
Read now
Articles from other publishers (37)
Kasper S Madsen, Pernille Kähler, Lise Katrine Aronsen Kähler, Sten Madsbad, Filip Gnesin, Maria-Inti Metzendorf, Bernd Richter & Bianca Hemmingsen. (2019) Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews.
Crossref
Crossref
L Adhikari, M. Semalty, P. S Naruka, V. K Aswal & A Semalty. (2019) BINARY COMPLEXES OF GLIMEPIRIDE WITH Β-CYCLODEXTRIN FOR IMPROVED SOLUBILITY AND DRUG DELIVERY. INDIAN DRUGS 56:03, pages 54-60.
Crossref
Crossref
Navneet Kumar Upadhyay, Charul Rathore, Sameer Sapra & Poonam Negi. (2018) NOVEL RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF SAXAGLIPTIN AND GLIMEPIRIDE. International Journal of Applied Pharmaceutics, pages 151-156.
Crossref
Crossref
A.P. Dewani, A.S. Tripathi, P.G. Shelke, R.L. Bakal, D.S. Mohale & A.V. Chandewar. (2017) Development of Solid-Phase Extraction and HPLC Method for Simultaneous Estimation of Ilaprazole and Glimepiride in Rat Plasma: Application to Pharmacokinetic Studies. Journal of Chromatographic Science.
Crossref
Crossref
Sandeep Lahiry, Avijit Kundu, Ayan Mukherjee, Shouvik Choudhury & Rajasree Sinha. (2017) Analyzing Antidiabetes Drug Prescriptions With World Health Organization Anatomical Therapeutic Chemical/Defined Daily Dose Index to Assess Drug Utilization Pattern in Elderly Population of Rural Eastern India. Indian Journal of Clinical Medicine 8, pages 117739361770334.
Crossref
Crossref
Bianca Hemmingsen, David Peick Sonne, Maria-Inti Metzendorf & Bernd Richter. (2016) Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2016:10.
Crossref
Crossref
Kasper S Madsen, Pernille Kähler, Lise Katrine Kähler, Sten Madsbad, Maria-Inti Metzendorf, Bernd Richter & Bianca Hemmingsen. (2016) Metformin and sulphonylurea (second- or third-generation) combination therapy for adults with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Bianca Hemmingsen, David Peick Sonne, Maria-Inti Metzendorf & Bernd Richter. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Eun-Yeong Kim, Keewon YuKyungmi ChoiHyung Eun Yu, Soo Jin Oh & Kiho Lee. (2015) Effect of Piperazine Dithioctate on the Oral Pharmacokinetics of Glimepiride in Rats. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 38:8, pages 1161-1168.
Crossref
Crossref
Abdul Bari Mohd, Krishna Sanka, Rakesh Gullapelly, Prakash V Diwan & Nalini Shastri. (2014) Development and validation of RP-HPLC method for glimepiride and its application for a novel self-nanoemulsifying powder (SNEP) formulation analysis and dissolution study. Journal of Analytical Science and Technology 5:1.
Crossref
Crossref
Giuseppe Derosa, Pietro Putignano, Antonio C. Bossi, Aldo Bonaventura, Fabrizio Querci, Ivano G. Franzetti, Barbara Guazzini, Gianpaolo Testori, Elena Fogari & Pamela Maffioli. (2011) Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients. European Journal of Pharmacology 666:1-3, pages 251-256.
Crossref
Crossref
Sujatha Samala, Sandhya Rani Tatipamula & Ciddi Veeresham. (2011) Determination of Glimepiride in Rat Serum by Rp-Hplc Method. American Journal of Analytical Chemistry 02:02, pages 152-157.
Crossref
Crossref
Giuseppe Derosa, Pamela Maffioli, Sibilla A.T. Salvadeo, Ilaria Ferrari, Alessia Gravina, Roberto Mereu, Ilaria Palumbo, Angela D'Angelo & Arrigo F.G. Cicero. (2009) Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study. Metabolism 58:8, pages 1059-1066.
Crossref
Crossref
Klaus Mengel. 2009. Arzneiverordnungs-Report 2009. Arzneiverordnungs-Report 2009
321
342
.
Klaus Mengel. 2008. Arzneiverordnungs-Report 2007. Arzneiverordnungs-Report 2007
327
346
.
Klaus Mengel. 2008. Arzneiverordnungs-Report 2008. Arzneiverordnungs-Report 2008
319
339
.
W T Cefalu, S Waldman & S Ryder. (2007) Pharmacotherapy for the Treatment of Patients with Type 2 Diabetes Mellitus: Rationale and Specific Agents. Clinical Pharmacology & Therapeutics 81:5, pages 636-649.
Crossref
Crossref
Hans-Georg Joost & Klaus Mengel. 2007. Arzneiverordnungs-Report 2006. Arzneiverordnungs-Report 2006
369
387
.
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
Giuseppe Derosa, Sibilla AT Salvadeo & Arrigo FG Cicero. (2006) Fixed-dose combination rosiglitazone/glimepiride in the treatment of Type 2 diabetes mellitus. Therapy 3:5, pages 559-569.
Crossref
Crossref
Giuseppe Derosa, Sibilla AT Salvadeo & Arrigo FG Cicero. (2006) Fixed-dose combination rosiglitazone/glimepiride in the treatment of Type 2 diabetes mellitus. Therapy 3:5, pages 559-569.
Crossref
Crossref
André Scheen. 2006. Nutrient-Drug Interactions. Nutrient-Drug Interactions
1
30
.
G. Derosa, A. V. Gaddi, M. N. Piccinni, S. Salvadeo, L. Ciccarelli, E. Fogari, M. Ghelfi, I. Ferrari & A. F. G. Cicero. (2006) Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial. Diabetes, Obesity and Metabolism 8:2, pages 197-205.
Crossref
Crossref
Hans-Georg Joost & Klaus Mengel. 2006. Arzneiverordnungs-Report 2005. Arzneiverordnungs-Report 2005
369
387
.
Giuseppe Derosa, Arrigo F.G. Cicero, Antonio V. Gaddi, Leonardina Ciccarelli, Mario N. Piccinni, Sibilla Salvadeo, Fabio Pricolo, Elena Fogari, Morena Ghelfi, Ilaria Ferrari & Roberto Fogari. (2005) Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: A 12-month, double-blind, randomized clinical trial. Clinical Therapeutics 27:9, pages 1383-1391.
Crossref
Crossref
Giuseppe Derosa, Arrigo F.G. Cicero, Antonio Gaddi, Pietro D. Ragonesi, Mario N. Piccinni, Elena Fogari, Sibilla Salvadeo, Leonardina Ciccarelli & Roberto Fogari. (2005) A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome. Diabetes Research and Clinical Practice 69:1, pages 5-13.
Crossref
Crossref
Giuseppe Derosa, Antonio V. Gaddi, Mario N. Piccinni, Leonardina Ciccarelli, Sibilla Salvadeo, Emmanouil Peros, Morena Ghelfi, Ilaria Ferrari & Arrigo F. G. Cicero. (2005) Antithrombotic Effects of Rosiglitazone-Metformin versus Glimepiride-Metformin Combination Therapy in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome. Pharmacotherapy 25:5, pages 637-645.
Crossref
Crossref
G Derosa, AV Gaddi, L Ciccarelli, E Fogari, M Ghelfi, I Ferrari & AFG Cicero. (2016) Long-term Effect of Glimepiride and Rosiglitazone on Non-conventional Cardiovascular Risk Factors in Metformin-treated Patients Affected by Metabolic Syndrome: A Randomized, Double-blind Clinical Trial. Journal of International Medical Research 33:3, pages 284-294.
Crossref
Crossref
. (2005) The Efficacy and Safety of Glimepiride in the Management of Type 2 Diabetes in Muslim Patients During Ramadan. Diabetes Care 28:2, pages 421-422.
Crossref
Crossref
Andr?? J Scheen. (2005) Drug Interactions of Clinical Importance with Antihyperglycaemic Agents. Drug Safety 28:7, pages 601-631.
Crossref
Crossref
Giuseppe DEROSA, Arrigo Francesco Giuseppe CICERO, Angela D'ANGELO, Antonio GADDI, Pietro Dario RAGONESI, Mario Nello PICCINNI, Sibilla SALVADEO, Leonardina CICCARELLI, Fabio PRICOLO, Morena GHELFI, Ilaria FERRARI, Lorenza MONTAGNA & Roberto FOGARI. (2005) Thiazolidinedione Effects on Blood Pressure in Diabetic Patients with Metabolic Syndrome Treated with Glimepiride. Hypertension Research 28:11, pages 917-924.
Crossref
Crossref
Giuseppe Derosa, Arrigo F.G Cicero, Antonio Gaddi, Pietro D Ragonesi, Elena Fogari, Gianandrea Bertone, Leonardina Ciccarelli & Mario N Piccinni. (2004) Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: A twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial. Clinical Therapeutics 26:5, pages 744-754.
Crossref
Crossref
Hans-Georg Joost & Klaus Mengel. 2004. Arzneiverordnungs-Report 2004. Arzneiverordnungs-Report 2004
300
317
.
Hans-Georg Joost & Klaus Mengel. 2004. Arzneiverordnungs-Report 2003. Arzneiverordnungs-Report 2003
210
227
.
Hans-Georg Joost & Klaus Mengel. 2003. Arzneiverordnungs-Report 2002. Arzneiverordnungs-Report 2002
170
185
.
. 2002. Changing Therapies in Type 2 Diabetes. Changing Therapies in Type 2 Diabetes
1
24
.
Hans-Georg Joost & Klaus Mengel. 2001. Arzneiverordnungs-Report 2001. Arzneiverordnungs-Report 2001
163
177
.